Editorial draft — not for publication yet. Midazolam content needs clinical and legal review before publication. This page is general information and is not advice about an individual prescription.

In short

Albion Laboratories Limited lists Mydlam-7.5 as a tablet containing midazolam BP 7.5 mg. This is a manufacturer listing from Bangladesh and does not verify a particular pack. The UK sources cited here describe specific midazolam formulations for supervised clinical sedation or seizure emergencies; check the live MHRA record or ask a UK pharmacist about Mydlam’s product-specific status. Do not use it to self-treat anxiety or insomnia.

For the general active-ingredient guide, continue to Midazolam medicine guide. This page covers Mydlam-specific product questions.

Mydlam UK product status

The manufacturer lists Mydlam-7.5 as a midazolam tablet. The UK sources reviewed for this guide describe other midazolam products and do not establish the UK authorisation status of Mydlam-7.5. Check the current MHRA products database or ask a UK pharmacist about the exact name, strength and manufacturer; authorisation of another midazolam formulation does not automatically apply to Mydlam.

What is Midazolam used for in UK clinical care?

Mydlam-7.5 is listed by its manufacturer as a midazolam tablet. That overseas product description is not evidence that the brand or tablet formulation is authorised for UK use. UK midazolam information found here applies to specific products and clinical settings, not automatically to Mydlam.

  • The manufacturer lists Mydlam-7.5 as a 7.5 mg midazolam tablet made by Albion Laboratories Limited in Bangladesh
  • UK midazolam product information includes injection for clinician-supervised procedural sedation, anaesthesia and intensive-care sedation
  • Buccal midazolam is used in a defined plan for prolonged seizures; this is a different formulation and purpose from a tablet for anxiety or sleep
  • We found no UK product information establishing Mydlam-7.5 as a routine UK treatment for anxiety or insomnia

The MHRA products database is the official place to check UK medicine product records. The UK sources reviewed for this guide identify other midazolam formulations, while Mydlam is identified in the manufacturer’s Bangladesh catalogue. This guide does not make a formal determination about Mydlam’s UK authorisation; check the live MHRA record and confirm with a pharmacist before publication.

NICE recommends buccal midazolam as one first-line option in a specific prolonged-seizure emergency plan. It does not recommend using Mydlam tablets as general self-treatment for anxiety or sleep.

How does it work?

Midazolam is a short-acting benzodiazepine that enhances inhibitory GABA signalling in the central nervous system. Its sedative effect can reduce alertness and impair memory, coordination and breathing. An unverified tablet cannot be assumed to contain midazolam or the stated strength, and a sedative effect does not make it an appropriate treatment for anxiety or insomnia.

Risks and possible effects

Sedation and impaired alertness

UK midazolam product information describes drowsiness, sedation, reduced alertness, impaired coordination and memory effects. Do not drive or operate machinery while affected; follow discharge instructions after procedural sedation.

Breathing problems or inability to wake

Midazolam can slow breathing, particularly with opioids, alcohol or other sedatives. Call 999 for severe or slow breathing, collapse, unconsciousness, seizure or inability to wake someone.

Safety information

  • A manufacturer catalogue entry does not verify an individual Mydlam pack, its contents, storage history or UK authorisation.
  • Do not use Mydlam to self-treat anxiety, panic or insomnia. Ask a GP about appropriate assessment and evidence-based treatment.
  • Midazolam with opioids, alcohol, sleeping tablets or other sedatives can cause profound sedation and dangerous breathing problems.
  • Midazolam formulations are not interchangeable. Do not substitute or convert doses between a tablet, injection, liquid or oromucosal syringe.
  • Do not take a prescription sedative supplied to somebody else or bought from an informal seller. Check online sellers using the MHRA register.

Mydlam and its stated active ingredient

Albion Laboratories Limited lists Mydlam-7.5 Tablet as containing midazolam BP 7.5 mg and identifies itself as a Bangladesh-based manufacturer. This reports what the manufacturer catalogue says; a product name or tablet marking cannot verify the contents of a separate pack.

“Mydlam” is the brand name and “midazolam” is the stated generic active ingredient. Strength, route, formulation, product authorisation and approved use depend on the exact product and country.

Mydlam UK status and product checks

The UK sources reviewed here describe other midazolam products, while Mydlam is identified in the manufacturer’s Bangladesh catalogue. This guide does not make a formal determination about Mydlam’s UK authorisation. Check the live MHRA products database or ask a UK pharmacist about the exact name, strength and manufacturer; authorisation of another formulation does not automatically apply to this brand.

If a website offers a prescription sedative, check the seller against the MHRA register; seller registration alone does not prove that an individual medicine is suitable or authorised.

How midazolam is used in UK clinical care

UK product information for midazolam injection describes use by clinicians for conscious sedation before or during selected procedures, anaesthesia and sedation in intensive care. These uses require a specific formulation, individual clinical assessment and appropriate monitoring.

NICE guidance also includes buccal midazolam in an emergency plan for prolonged convulsive seizures. Buccal solution in a pre-filled syringe is not the same product as a 7.5 mg tablet and should only be used according to the person’s prescribed seizure plan.

Mydlam for anxiety or sleep?

We found no UK product information establishing Mydlam-7.5 as a UK anxiety or insomnia treatment. Midazolam can cause sedation, but being sleepy is not the same as treating the cause of anxiety or a persistent sleep problem. Do not take it to calm yourself or make yourself sleep.

A GP can assess anxiety and discuss suitable support, including psychological treatment and appropriate medicines. For insomnia that lasts for months or affects daily life, NHS advice is to speak with a GP about possible causes and treatment.

Sedation, breathing and medicine interactions

Midazolam can cause drowsiness, reduced alertness, memory effects and impaired coordination. Its effects may be stronger or last longer depending on individual health factors and other medicines. Follow the leaflet for the exact prescribed product and do not drive while affected.

Combining midazolam with opioids, alcohol, sleeping medicines or other sedatives can cause profound sedation and dangerous respiratory depression. Tell a clinician about all medicines and substances before receiving procedural sedation. Call 999 for severe breathing difficulty, collapse, unconsciousness or inability to wake.

If you took an unknown tablet or too much

If someone may have taken too much midazolam or an unknown tablet sold as Mydlam, get medical advice immediately. Call 999 for unconsciousness, inability to wake, severe breathing difficulty, collapse or seizure. If there are no emergency symptoms but you are unsure whether the substance or amount is harmful, contact NHS 111 urgently.

Do not give more sedatives or alcohol, do not try to make the person vomit and do not delay a call for help to identify the pack. Keep the packaging available for clinicians if it is safe to do so.

Frequently asked questions

What is Mydlam?

Albion Laboratories Limited lists Mydlam-7.5 as a tablet containing midazolam BP 7.5 mg. This is a manufacturer listing from Bangladesh and does not verify a particular pack or establish UK authorisation.

Is Mydlam available in the UK?

The UK sources reviewed here do not establish the authorisation status of Mydlam. Check the live MHRA products database or ask a UK pharmacist about the exact product; another midazolam product’s authorisation does not automatically apply to Mydlam.

Can I take Mydlam for anxiety or sleep?

Do not self-treat anxiety or insomnia with Mydlam. We found no UK product information establishing this brand and tablet as a UK treatment for either condition. Speak with a GP about safe options.

Is Mydlam the same as Buccolam?

No. Mydlam-7.5 is listed as a tablet, whereas Buccolam is a specific oromucosal midazolam solution used in a prescribed seizure-emergency plan. Do not substitute or convert doses.

What should I do if I took an unknown Mydlam tablet?

Call 999 for severe breathing difficulty, unconsciousness, collapse, seizure or inability to wake. If there are no emergency symptoms but you are unsure of the risk, contact NHS 111 urgently.

Explore the detailed mydlam (midazolam) guides

Each guide answers a different practical question. Advice is specific to midazolam and should be checked against your own product leaflet and prescription.

Sources and review

This draft was checked against the sources below on 2 October 2026. It still requires clinical and legal review before publication.

Editorial status: Clinical and regulatory review required before publication.